These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 8674661)
1. Elucidation of D3 receptor function in vivo: do D3 receptors mediate inhibition of dopamine neuronal activity? Routledge C; Thorn L; Ashmeade T; Taylor S Biochem Soc Trans; 1996 Feb; 24(1):199-201. PubMed ID: 8674661 [No Abstract] [Full Text] [Related]
2. Differential effects of dopamine agonists on evoked dopamine release from slices of striatum and nucleus accumbens in rats. Yamada S; Yokoo H; Nishi S Brain Res; 1994 Jun; 648(1):176-9. PubMed ID: 7922522 [TBL] [Abstract][Full Text] [Related]
3. Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities. Kreiss DS; Bergstrom DA; Gonzalez AM; Huang KX; Sibley DR; Walters JR Eur J Pharmacol; 1995 Apr; 277(2-3):209-14. PubMed ID: 7493610 [TBL] [Abstract][Full Text] [Related]
4. Gradient of dopamine responsiveness to dopamine receptor agonists in subregions of the rat nucleus accumbens. Shilliam CS; Heidbreder CA Eur J Pharmacol; 2003 Sep; 477(2):113-22. PubMed ID: 14519414 [TBL] [Abstract][Full Text] [Related]
5. Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat. Barik S; de Beaurepaire R Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):718-26. PubMed ID: 15913875 [TBL] [Abstract][Full Text] [Related]
6. Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors. Svensson K; Carlsson A; Huff RM; Kling-Petersen T; Waters N Eur J Pharmacol; 1994 Oct; 263(3):235-43. PubMed ID: 7843260 [TBL] [Abstract][Full Text] [Related]
7. Reevaluation of the two-component hypothesis for turning behaviour by manipulating activities in the striatum and the nucleus accumbens of intact rats. Saigusa T; Koshikawa N; Kitamura M; Kobayashi M Eur J Pharmacol; 1993 Jun; 237(2-3):161-8. PubMed ID: 8103458 [TBL] [Abstract][Full Text] [Related]
8. Functional roles of dopamine D2 and D3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo. Tepper JM; Sun BC; Martin LP; Creese I J Neurosci; 1997 Apr; 17(7):2519-30. PubMed ID: 9065512 [TBL] [Abstract][Full Text] [Related]
9. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Wachtel SR; Hu XT; Galloway MP; White FJ Synapse; 1989; 4(4):327-46. PubMed ID: 2532422 [TBL] [Abstract][Full Text] [Related]
10. Intra-accumbens infusion of D(3) receptor agonists reduces spontaneous and dopamine-induced locomotion. Ouagazzal AM; Creese I Pharmacol Biochem Behav; 2000 Nov; 67(3):637-45. PubMed ID: 11164096 [TBL] [Abstract][Full Text] [Related]
11. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the effect of dopamine D3 receptor stimulation on locomotion and striatal dopamine levels. De Boer P; Enrico P; Wright J; Wise LD; Timmerman W; Moor E; Dijkstra D; Wikström HV; Westerink BH Brain Res; 1997 May; 758(1-2):83-91. PubMed ID: 9203536 [TBL] [Abstract][Full Text] [Related]
14. Evidence to suggest that agonist modulation of hyperlocomotion is via post-synaptic dopamine D2 or D3 receptors. Thorn L; Ashmeade TE; Storey VJ; Routledge C; Reavill C Neuropharmacology; 1997 Jun; 36(6):787-92. PubMed ID: 9225306 [TBL] [Abstract][Full Text] [Related]
15. Tyrosine-induced release of dopamine is under inhibitory control of presynaptic dopamine D2 and, probably, D3 receptors in the dorsal striatum, but not in the nucleus accumbens. Fusa K; Saigusa T; Koshikawa N; Cools AR Eur J Pharmacol; 2002 Jul; 448(2-3):143-50. PubMed ID: 12144934 [TBL] [Abstract][Full Text] [Related]
16. Quinpirole-induced 50 kHz ultrasonic vocalization in the rat: role of D2 and D3 dopamine receptors. Brudzynski SM; Komadoski M; St Pierre J Behav Brain Res; 2012 Jan; 226(2):511-8. PubMed ID: 22015714 [TBL] [Abstract][Full Text] [Related]
18. Role of dopamine D1 and D2 receptors in the nucleus accumbens in jaw movements of rats: a critical role of the shell. Cools AR; Miwa Y; Koshikawa N Eur J Pharmacol; 1995 Nov; 286(1):41-7. PubMed ID: 8566150 [TBL] [Abstract][Full Text] [Related]
19. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways. Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181 [TBL] [Abstract][Full Text] [Related]
20. Regional differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-D-aspartate receptor activation in rat nucleus accumbens and neostriatum. Henselmans JM; Stoof JC Brain Res; 1991 Dec; 566(1-2):1-7. PubMed ID: 1687661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]